Purpose Canadian Financial Income Series A T.BNC

Voting against the 14c acquisition

[scroll4facts]

I'm going to vote against this 14c "deal" unless the BOD convince me that everything else has been done to maximize the shareholder value.  I'd rather risk having a somewhat lower bid later on than surrender to such an unbelievable offer.  I mean, has every pharmas, biotechs, edge funds and younamethem contacted offered less than $8M for two plants, IP, MCNA and $50M in tax attributes?  Serious?  Those are worth well north of $100M in my opinion.  Why not send an invitation for an auction to some players like Roche, MRK, ENDO, LLY, BMY, GSK, NVS, PFE and AZN to name a few, or place an ad on eBay with a starting bid at $10M?  Remember that MCNA performed much better than the alternative chemo in the pivotal clinical trial according to the links below.  Adverse events were 1.5% versus 30.0% and the efficacy 100%-250% higher.  I think that MCNA is not worthless and is not dead.  The FDA is just requesting another P3 trial, a more robust one.  I figure that any major pharma or biotech daring to invest roughly $50M and wait another 5 years could see earnings reaching hundreds of millions of dollars in return.

https://seekingalpha.com/instablog/592211-john-h-ford/4491146-telesta-therapeutics-near-term-catalyst-provide-multi-bagger-returns

https://en.wikipedia.org/wiki/Telesta_Therapeutics

[scroll4facts]

Typo:  hedge fund

[Biostocks01]

No it will be no other offers!! Ipsen was our last chance to save the MCNA... If this offer is refused, the share price will fall to 4 cents. Mark my words!! Bio

[rgonlyfactspls]

Dear Biostocks01 & TheGreatKazooooooooo (bless youuuuuu, hopefully it's only a cold or seasonal allergies)...If MCNA is truly out of the picture THEN the potential buyer is primarily buying hard, cold CASH in TST's bank account (forgetting a few other assets). As the analysts of PLI have already broken down the components of the deal, CASH (in the bank) accounts for almost 80% of the